Director · GRI Bio, Inc. · GRI Bio, Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
3,935
Price
—
Executed
Nov 4, 2026
Disclosed
Nov 13, 2026
Disclosure timeline9 days from execution to publication · legal deadline 2 business days
Nov 4 executedNov 13, 2026 disclosed
GRI · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+10 / 15
Disclosed 7 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Rongen Roelof filed this Form 4 reporting a grant or award of GRI on Nov 4, 2026. It became public on Nov 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Rongen Roelofcik:0001698966
Issuer
GRI Bio, Inc.cik:0001824293
Revision history · 0
No field has changed since this record was first ingested.
